These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 34876670)

  • 1. Acute exacerbation of interstitial lung disease associated with rheumatic disease.
    Luppi F; Sebastiani M; Salvarani C; Bendstrup E; Manfredi A
    Nat Rev Rheumatol; 2022 Feb; 18(2):85-96. PubMed ID: 34876670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
    Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
    Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
    Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
    BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, risk factors, and prognosis of acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
    Xie M; Zhu C; Ye Y
    BMC Pulm Med; 2023 Jul; 23(1):255. PubMed ID: 37434169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases.
    Salonen J; Purokivi M; Bloigu R; Kaarteenaho R
    BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32265195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: Comparison with idiopathic pulmonary fibrosis.
    Otsuka J; Yoshizawa S; Kudo K; Osoreda H; Ishimatsu A; Taguchi K; Moriwaki A; Wakamatsu K; Iwanaga T; Yoshida M
    Respir Med; 2022; 200():106898. PubMed ID: 35696743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.
    Singh P; Thakur B; Mohapatra AK; Padhan P
    Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Exacerbation in Interstitial Lung Disease.
    Leuschner G; Behr J
    Front Med (Lausanne); 2017; 4():176. PubMed ID: 29109947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between acute exacerbation and progressive pulmonary fibrosis in interstitial lung disease: a retrospective cohort study.
    Zhai L; Wang Z; Yu W
    Ther Adv Respir Dis; 2024; 18():17534666241276800. PubMed ID: 39235441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
    Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
    Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acute exacerbations of interstitial lung disease.
    Azadeh N; Moua T; Baqir M; Ryu JH
    Expert Rev Respir Med; 2018 Apr; 12(4):309-313. PubMed ID: 29486130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease.
    Ba C; Jiang C; Wang H; Shi X; Jin J; Fang Q
    Ther Adv Respir Dis; 2024; 18():17534666241250332. PubMed ID: 38757948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases.
    Enomoto N; Naoi H; Mochizuka Y; Isayama T; Tanaka Y; Fukada A; Aono Y; Katsumata M; Yasui H; Mori K; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    BMC Pulm Med; 2022 Oct; 22(1):387. PubMed ID: 36289542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical manifestations and prognostic factors analysis of patients hospitalised with acute exacerbation of idiopathic pulmonary fibrosis and other interstitial lung diseases.
    Ba C; Wang H; Jiang C; Shi X; Jin J; Fang Q
    BMJ Open Respir Res; 2024 Feb; 11(1):. PubMed ID: 38413119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases.
    Salonen J; Vähänikkilä H; Purokivi M; Kaarteenaho R
    PLoS One; 2020; 15(11):e0242860. PubMed ID: 33253258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute exacerbations of fibrotic interstitial lung diseases.
    Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
    Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases.
    Lee JH; Jang JH; Park JH; Jang HJ; Park CS; Lee S; Kim SH; Kim JY; Kim HK
    PLoS One; 2021; 16(7):e0255365. PubMed ID: 34314462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model.
    Hozumi H; Kono M; Hasegawa H; Kato S; Inoue Y; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
    Respir Res; 2022 Mar; 23(1):57. PubMed ID: 35277175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature.
    Manfredi A; Sebastiani M; Cerri S; Vacchi C; Tonelli R; Della Casa G; Cassone G; Spinella A; Fabrizio P; Luppi F; Salvarani C
    J Thorac Dis; 2019 Apr; 11(4):1621-1628. PubMed ID: 31179106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: More questions than answers.
    Luppi F; Manfredi A; Faverio P; Franco G; Salvarani C; Bendstrup E; Sebastiani M
    Autoimmun Rev; 2024 Dec; 23(12):103668. PubMed ID: 39413945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.